U.S. net product sales revenue for the first full calendar year of commercialization of XPHOZAH was $160.9 million, including $57.2 million in net product sales revenue during the fourth quarter of ...
Company achieved significant commercial progress in 2024, finishing with total revenue of $333.6 million, including $319.2 million in U.S. Net Product Sales Company reaffirms combined peak sales of IB ...
A new study from Karolinska Institutet shows that severe mental illness is more common in patients with chronic kidney ...
Artificial intelligence is making its way into medicine quickly , even keeping some people alive. It’s come to be a key part ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback